Search

everythinglearnresearchcommunity

for

Search:↓

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

People with alopecia areata are more likely to have other immune-related conditions.

New treatments and understanding of skin lupus are emerging in 2024.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

COVID-19 infection or vaccination may trigger lichen planus.

Patients with lichen planus should be tested for hepatitis C.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Psoriasis is a common skin disorder caused by immune system issues, treatable with various therapies.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

VKHD and sarcoidosis may share a common cause.

A(1-7) treatment reduces symptoms of lupus in mice.